These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 33555114)

  • 21. Left atrial decompression through unidirectional left-to-right interatrial shunt for the treatment of left heart failure: first-in-man experience with the V-Wave device.
    Amat-Santos IJ; Bergeron S; Bernier M; Allende R; Barbosa Ribeiro H; Urena M; Pibarot P; Verheye S; Keren G; Yaacoby M; Nitzan Y; Abraham WT; Rodés-Cabau J
    EuroIntervention; 2015 Jan; 10(9):1127-31. PubMed ID: 24832489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.
    Wessler J; Kaye D; Gustafsson F; Petrie MC; Hasenfuβ G; Lam CSP; Borlaug BA; Komtebedde J; Feldman T; Shah SJ; Burkhoff D;
    Circ Heart Fail; 2018 Aug; 11(8):e004540. PubMed ID: 30354556
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure.
    Borlaug BA; Blair J; Bergmann MW; Bugger H; Burkhoff D; Bruch L; Celermajer DS; Claggett B; Cleland JGF; Cutlip DE; Dauber I; Eicher JC; Gao Q; Gorter TM; Gustafsson F; Hayward C; van der Heyden J; Hasenfuß G; Hummel SL; Kaye DM; Komtebedde J; Massaro JM; Mazurek JA; McKenzie S; Mehta SR; Petrie MC; Post MC; Nair A; Rieth A; Silvestry FE; Solomon SD; Trochu JN; Van Veldhuisen DJ; Westenfeld R; Leon MB; Shah SJ;
    Circulation; 2022 May; 145(21):1592-1604. PubMed ID: 35354306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-Year Outcomes of an Atrial Shunt Device in HFpEF/HFmrEF: Results From REDUCE LAP-HF II.
    Gustafsson F; Petrie MC; Komtebedde J; Swarup V; Winkler S; Hasenfuß G; Borlaug BA; Mohan RC; Flaherty JD; Sverdlov AL; Fail PS; Chung ES; Lurz P; Lilly S; Kaye DM; Cleland JGF; Cikes M; Leon MB; Cutlip DE; van Veldhuisen DJ; Solomon SD; Shah SJ
    JACC Heart Fail; 2024 Aug; 12(8):1425-1438. PubMed ID: 38934964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcatheter Interatrial Shunt Device for the Treatment of Heart Failure: Rationale and Design of the Randomized Trial to REDUCE Elevated Left Atrial Pressure in Heart Failure (REDUCE LAP-HF I).
    Feldman T; Komtebedde J; Burkhoff D; Massaro J; Maurer MS; Leon MB; Kaye D; Silvestry FE; Cleland JG; Kitzman D; Kubo SH; Van Veldhuisen DJ; Kleber F; Trochu JN; Auricchio A; Gustafsson F; Hasenfuβ G; Ponikowski P; Filippatos G; Mauri L; Shah SJ
    Circ Heart Fail; 2016 Jul; 9(7):. PubMed ID: 27330010
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interatrial Shunt Devices.
    Salah HM; Baratto C; Yaranov DM; Rommel KP; Achanta S; Caravita S; Reddy Vasanthu VK; Fudim M
    Heart Fail Clin; 2024 Jan; 20(1):61-69. PubMed ID: 37953022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.
    Kaye DM; Petrie MC; McKenzie S; Hasenfuβ G; Malek F; Post M; Doughty RN; Trochu JN; Gustafsson F; Lang I; Kolodziej A; Westenfeld R; Penicka M; Rosenberg M; Hausleiter J; Raake P; Jondeau G; Bergmann MW; Spelman T; Aytug H; Ponikowski P; Hayward C;
    ESC Heart Fail; 2019 Feb; 6(1):62-69. PubMed ID: 30311437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical study on the treatment of chronic heart failure with a novel D-shant atrium shunt device.
    Shang X; Liu M; Zhong Y; Wang X; Chen S; Fu X; Sun M; Xie M; Ke Y; Guan Y; Zhang C; Dong N
    ESC Heart Fail; 2022 Jun; 9(3):1713-1720. PubMed ID: 35179320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction: early results of the REBALANCE-HF trial roll-in cohort.
    Fudim M; Fail PS; Litwin SE; Shaburishvili T; Goyal P; Hummel SL; Borlaug BA; Mohan RC; Patel RB; Mitter SS; Klein L; Rocha-Singh K; Patel MR; Reddy VY; Burkhoff D; Shah SJ
    Eur J Heart Fail; 2022 Aug; 24(8):1410-1414. PubMed ID: 35598154
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Percutaneous Atriotomy for Levoatrial-to-Coronary Sinus Shunting in Symptomatic Heart Failure: First-in-Human Experience.
    Simard T; Labinaz M; Zahr F; Nazer B; Gray W; Hermiller J; Chaudhry SP; Guimaraes L; Philippon F; Eckman P; Rodés-Cabau J; Sorajja P; Hibbert B
    JACC Cardiovasc Interv; 2020 May; 13(10):1236-1247. PubMed ID: 32438996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure.
    Kaye D; Shah SJ; Borlaug BA; Gustafsson F; Komtebedde J; Kubo S; Magnin C; Maurer MS; Feldman T; Burkhoff D
    J Card Fail; 2014 Mar; 20(3):212-21. PubMed ID: 24487087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interatrial shunt therapy in advanced heart failure: Outcomes from the open-label cohort of the RELIEVE-HF trial.
    Rodés-Cabau J; Lindenfeld J; Abraham WT; Zile MR; Kar S; Bayés-Genís A; Eigler N; Holcomb R; Núñez J; Lee E; Perl ML; Moravsky G; Pfeiffer M; Boehmer J; Gorcsan J; Bax JJ; Anker S; Stone GW
    Eur J Heart Fail; 2024 Apr; 26(4):1078-1089. PubMed ID: 38561314
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Feasibility and efficacy of transcatheter interatrial shunt devices for chronic heart failure: a systematic review and meta-analysis.
    Lauder L; Pereira TV; Degenhardt MC; Ewen S; Kulenthiran S; Coats AJS; Böhm M; Anker SD; da Costa BR; Mahfoud F
    Eur J Heart Fail; 2021 Nov; 23(11):1960-1970. PubMed ID: 34628706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biventricular longitudinal strain as a predictor of functional improvement after D-shant device implantation in patients with heart failure.
    Zhou Y; Li H; Fang L; Wu W; Sun Z; Zhang Z; Liu M; Liu J; He L; Chen Y; Xie Y; Li Y; Xie M
    Front Cardiovasc Med; 2023; 10():1121689. PubMed ID: 37139125
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atrial Fibrillation in Heart Failure With Preserved Ejection Fraction: Association With Exercise Capacity, Left Ventricular Filling Pressures, Natriuretic Peptides, and Left Atrial Volume.
    Lam CS; Rienstra M; Tay WT; Liu LC; Hummel YM; van der Meer P; de Boer RA; Van Gelder IC; van Veldhuisen DJ; Voors AA; Hoendermis ES
    JACC Heart Fail; 2017 Feb; 5(2):92-98. PubMed ID: 28017355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Surgical ablation of the right greater splanchnic nerve for the treatment of heart failure with preserved ejection fraction: first-in-human clinical trial.
    Málek F; Gajewski P; Zymliński R; Janczak D; Chabowski M; Fudim M; Martinca T; Neužil P; Biegus J; Mates M; Krüger A; Skalský I; Bapna A; Engelman ZJ; Ponikowski PP
    Eur J Heart Fail; 2021 Jul; 23(7):1134-1143. PubMed ID: 33932262
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, usability, and performance of a wireless left atrial pressure monitoring system in patients with heart failure: the VECTOR-HF trial.
    D'Amario D; Meerkin D; Restivo A; Ince H; Sievert H; Wiese A; Schaefer U; Trani C; Bayes-Genis A; Leyva F; Whinnett ZI; Di Mario C; Jonas M; Manhal H; Amat-Santos IJ; Del Trigo M; Gal TB; Avraham BB; Hasin T; Feickert S; D'Ancona G; Altisent OA; Koren O; Caspi O; Abraham WT; Crea F; Anker SD; Kornowski R; Perl L;
    Eur J Heart Fail; 2023 Jun; 25(6):902-911. PubMed ID: 37092287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and Safety of Inter-Atrial Shunt Devices for Heart Failure With Reduced or Preserved Ejection Fraction: Early Experiences.
    Lu D; Zhu J; Liao B
    Heart Lung Circ; 2018 Mar; 27(3):359-364. PubMed ID: 28483550
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Left atrial remodeling and function in advanced heart failure with preserved or reduced ejection fraction.
    Melenovsky V; Hwang SJ; Redfield MM; Zakeri R; Lin G; Borlaug BA
    Circ Heart Fail; 2015 Mar; 8(2):295-303. PubMed ID: 25593126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creation of a restrictive atrial communication in heart failure with preserved and mid-range ejection fraction: effective palliation of left atrial hypertension and pulmonary congestion.
    Bauer A; Khalil M; Lüdemann M; Bauer J; Esmaeili A; De-Rosa R; Voelkel NF; Akintuerk H; Schranz D
    Clin Res Cardiol; 2018 Sep; 107(9):845-857. PubMed ID: 29663123
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.